Search
Cogent Biosciences Inc
COGTAdd to Watchlist
31.020USD
-0.940-2.94%
Close 10-30 16:00（ET）
5.38BMarket Cap
LossP/E TTM
Cogent Biosciences Inc (COGT) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Cogent Biosciences Inc in the past month.
Buy
6 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
55.200USD+71.27%
COGT Analyst Recommendation Trends
In the current month, COGT has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. COGT average Analyst price target in the last month is 55.200.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
1
1
1
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
12
13
13
13
13
13
COGT Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
11
8
0
0
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Financial Forecasting
Based on analysts' estimates, COGT EPS is projected to reach -0.565 in FY2026Q3, following reported EPS of -0.520 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.51
-0.54
-0.57
-0.57
-0.57
Actual
-0.59
-0.53
-0.52
--
--
Surprise
-14.48%
+1.94%
+8.65%
--
--
FAQs
What is Cogent Biosciences Inc's price target?
Analysts forecast that Cogent Biosciences Inc's price target is USD 55.20, with the highest forecast at USD 60.00 and the lowest forecast at USD 45.00.
How have Cogent Biosciences IncCOGT's recent earnings per share performed?
The market expectation was USD -0.52, while Cogent Biosciences IncCOGT's earnings per share (EPS) for the previous quarter was USD -0.53. EPS for the next quarter is expected at USD -0.57.
What is the analyst rating for Cogent Biosciences Inc?
Based on the ratings of Cogent Biosciences Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.